This infographic examines the top 5 outpatient imaging services (for-profit) in Europe for 2023, with a comparison to 2022. The ranking is based on companies' outpatient imaging services revenues, sourced from HBI Intelligence.
Europe’s occupational health market is seeing growing interest from investors as employers across the continent become increasingly amenable to taking a proactive approach to supporting their employees’ health. The sector is beginning to see significant M&A and PE acquisitions.
German multinational medtech firm Siemens Healthineers is going to acquire the diagnostic division of Swiss-based multinational pharmaceutical company, Novartis AG.
This infographic looks at the top 10 for-profit healthcare sectors and the respective providers in France. The list is based on the operator revenue for the year 2022, drawn from HBI Intelligence.
PAI Partners, the French private equity firm, is in talks with two of the world's largest sovereign wealth funds to support its offer for Sanofi SA's consumer health division. According to anonymous Bloomberg sources, the Abu Dhabi Investment Authority (ADIA) and Singapore's GIC Pte are considering joining PAI's consortium. The deal could value the business […]
The UK, Germany, and France lead in veterinary diagnostics, while southern Europe lags According to UK’s online pet marketplace Pets4Homes, demand for puppies for sale rose by 104% at the peak of the lockdown in May 2020. S&P Global notes animal diagnostics is now a growing area. MI:RNA Diagnostics, a Scottish veterinary diagnostics company, […]
PE firm Cinven will become the largest investor in Swedish healthy drinks and snacks company Vitamin Well, pending completion of the transaction in the second half of this year subject to regulatory approvals and other customary closing conditions.
Unilabs, a Swiss diagnostics company, has partnered with US-based medtech C2N Diagnostics to exclusively distribute C2N’s Alzheimer’s blood tests across the EU, including Norway, Switzerland, the U.K., Peru, Saudi Arabia, and the UAE.
Multinational listed French nursing home giant emeis has reported strong revenue and occupancy growth for the first half of 2024. But the company’s H1 results also included a downgraded EBITDAR forecast for 2024, causing the company’s share price to fall 26%.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.